The Triple Challenge of Triple Therapy

Publié dans Journal of the American College of Cardiology : Cardiovascular Interventions 2016 Aug 22;9(16):1703-5 Auteurs : Collet JP, Guedeney P, Montalescot G. Article disponible en consultant le site Editorial comment The addition of dual antiplatelet (DAPT) therapy to oral anticoagulant triples the risk of major bleeding complications. Patients who are exposed to triple therapy…

Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries.

Publié dans European Heart Journal - Cardiovascular Pharmacotherapy 2016 Jul;2(3):152-67 Auteurs : Danchin N, Lettino M, Zeymer U, Widimsky P, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Lopez Sendón J, Tousek…

Individualized Modeling Approach for DAPT Duration

Publié dans Journal of the American College of Cardiology 2016 May 17;67(19):2235-6 Auteurs : Collet JP, Fischer Q, Montalescot G. Article disponible en consultant le site Editorial comment Duration of dual antiplatelet therapy (DAPT) after coronary stenting remains controversial, as do the drivers of the decision-making. Is it the stent, the coronary anatomy, the patient…

Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated with Prasugrel : The ACCOAST Access Substudy

Publié dans Journal of the American College of Cardiology : Cardiovascular Interventions 2016 May 9;9(9):897-907 Auteurs : Porto I, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay JF, Ten Berg J, Widimský P, Le Gall N, Zagar AJ, LeNarz LA, Miller D, Montalescot G; ACCOAST Investigators. Article disponible en consultant le site Abstract Background…